John R. "Jack" Fowle III

Experience

• 

  Other Positions

  Jun 1970 - Apr 1979

  Various

  Worked for a contractor to the Environmental Protection Agency, taught introductory genetics at George Washington University, served as a Park Ranger Naturalist for the National Park Service.

• 

  US EPA

  Apr 1979 - Dec 1991

  Planned and managed the development of ORD’s biotechnology research program. Organized and conducted workshops with the American Association for the Advancement of Science (AAAS) to: 1) identify program office research needs, 2) peer review research plans, and 3) explore short-term ecological effects of biotechnology products. Coordinated activities of EPA’s five research offices to: 1) identify research needs, 2) identify personnel and resource requirements, 3) define facility requirements, 4) compare current resources with needs, and 5) develop options and recommendations. Developed and monitored three contracts totaling $102K. Prepared three internal reports and published one article. Prepared and defended resource requests. The plan provided the basis for a successful budget initiative in FY 1985 leading to a program funded for 8 years. EPA representative on the NIH Recombinant DNA Advisory Committee and to its Deliberate Release Workgroup. Member of the U.S. Delegation to the Organization for Economic Cooperation and Development (OECD) Biotechnology Risk Assessment Workgroup, attending meetings in Paris and Washington. Helped negotiate and write the OECD Biotechnology Policy document. Show less

  • Associate Laboratory Director for Water Health Effects Research Lab

    Jan 1989 - Dec 1991

  • Health Science Advisor to the Assistant Administrator for Research and Development

    Jan 1988 - Jan 1989

  • Director Environmental Health Research Staff

    Nov 1984 - Dec 1988

  • Congressional Liaison to Congressman Albert D. Gore (EPA Detailee)

    Sept 1984 - Nov 1984

  • ORD Biotechnology Coordinator

    Nov 1983 - Sept 1984

  • Geneticist, Reproductive Effects Assessment Group, ORD

    Aug 1980 - Nov 1983

  • Geneticist, Carcinogen Assessment Group

    Apr 1979 - Aug 1980
• 

  United States Senate

  Jan 1992 - Dec 1994

  Science Advisor to Senator Daniel Patrick Moynihan

  Advised Senator Moynihan and his staff about the science issues facing Congress. Drafted legislation and negotiated with staff of other Senators to develop workable legislative packages. Negotiated with House staff members to reconcile differences between Senate passed and House passed bills. Met and regularly discussed Senator Moynihan’s science legislative goals and interests with the press.

• 

  US EPA

  Jan 1995 - Aug 2007

  Directed, planned and managed EPA's Toxic Substances, Pesticides and Endocrine Disrupting effects research program. Matrix managed 120 FTEs. Multiyear Plan lead responsible for ORD's overall research in support of the Office of Prevention, Pesticides and Toxic Substances (OPPTS). Directed the development of the Safe Pesticides/Safe Products (SP2) Multiyear Plan. Directed the development of the Effects Laboratory's SP2 Implementation Plan ensuring that key regulatory program leadership and technical staff were engaged with key laboratory managers and technical staff. Laboratory lead for biotechnology program development. Member Computational Toxicology Research Program Design and Implementation Teams. Laboratory lead for Nanotechnology Research Program Design Team. Show less Directed the multi-disciplinary staff of health, ecology and social science professionals who operated EPA's Science Advisory Board. Managed the Office's budget and operations (e.g. compliance with FMFIA, GPRA, Federal Advisory Committee Act (FACA) requirements). Managed the project and member selection process including world-renowned experts in the biological, chemical, physical and social sciences. Served as Designated Federal Officer for the Research Strategies Advisory Committee. Managed committee operations and interactions with the Agency and Congress. Co-chaired EPA's Science Policy Council's risk characterization guidance implementation. Member Risk Assessment Forum. Show less

  • Assistant Lab Director for Toxics & Pesticides, National Health and Environmental Effects Research L

    Feb 2002 - Aug 2007

  • Deputy Director, Office of the Science Advisory Board

    Sept 1995 - Jan 2002

  • Health Advisor to the Assistant Administrator for Research and Development

    Jan 1995 - Aug 1995
• 

  U.S. Environmental Protection Agency, National Health and Environmental Effects Research Laboratory

  Aug 2007 - Apr 2009

  Acting Director, Neurotoxicology Division

  Directed a multi-disciplinary staff of over 50 health professionals to conduct research on the ability of environmental pollutants to damage the nervous system and the brain. Provided scientific and policy guidance and direction to the staff to ensure cutting edge research focused on EPA's mission by informing Agency decisions, primarily through improving the Agency's capacity to conduct risk assessment. Utilized network of contacts with senior Agency officials to ensure that work was responsive to the most pressing Agency needs. Managed the Division's budget and operations and worked with Branch Chiefs and Administrative Staff to ensure compliance with Federal Managers Financial Integrity Act (FMFIA), Government Performance and Results Act (GPRA), and other requirements. As part of the senior laboratory management team developed ways to maintain program focus and productivity while sustaining a 20 % cut in FTEs and a loss of funds for extramural support. Show less

• 

  US EPA

  Jun 2009 - Dec 2011

  Deputy Director Health Effects Division Office of Pesticide Programs

  Directed a multidisciplinary group of scientists conducting health risk assessment activities supporting the re-registration of existing pesticides. Managed technical teams developing assessments of various high visibility, high priority efforts such as the atrazine and endosulfan risk assessments, and the pyrethroid cumulative risk assessment project. Engaged scientific communities both within OPP and at the broader national and international scientific community levels by providing scientific and programmatic leadership on activities such as efforts to implement the Tox 21 vision to improve risk assessment. Helped manage the integration of new toxicological approaches into OPP’s human health risk assessments, including coordination of the Interagency Coordinating Committee for the Validation of Alternative Methods (ICCVAM) activities across EPA. Co-Chaired the OECD Validation Method Group-Non Animal (VMG-NA) Committee for assessing endocrine disrupting chemicals in 2011. Show less

• 

  Science To Inform, L.L.C.

  Jan 2012 - now

  Principal

  Supporting the development and acceptance of Toxicity Testing in the 21st Century through the use of Adverse Outcome Pathways and an integrated approach to testing and assessment incorporating more informative, efficient and economical testing and assessment approaches including alternatives to animal testing. Science Policy, Regulatory Science and Risk Assessment